New COVID-19 vaccines considered effective against the omicron variant will be available to all people who have completed at least two inoculations from as early as mid-October, the government said Monday.
The bivalent vaccines, so named for their combination of ingredients deriving from existing COVID-19 shots and from omicron’s BA.1 subvariant, have been reported to provide some increase in neutralizing antibodies against the https://www.japantimes.co.jp/news/2022/07/28/national/science-health/covid-surge-ba-5-explainer/”>BA.5 subtype currently https://www.japantimes.co.jp/news/2022/08/06/national/coronavirus-measures-prefectures/”>prevalent across the country.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
https://www.japantimes.co.jp/subscribe/?utm_source=jto&utm_medium=general-box&utm_campaign=sub” class=”general-box_sub”>SUBSCRIBE NOW
https://www.japantimes.co.jp/news/2022/08/08/national/japan-omicron-vaccine-eligibility/”>